bluebird bio, Inc.·4

Dec 12, 4:01 PM ET

Obenshain Andrew 4

4 · bluebird bio, Inc. · Filed Dec 12, 2024

Insider Transaction Report

Form 4
Period: 2024-12-10
Obenshain Andrew
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2024-12-10$0.42/sh971$405374,247 total
Footnotes (1)
  • [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.

Documents

2 files